NON-SMALL CELL LUNG CANCER STAGE II
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE II explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE II trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to keep early lung cancer from coming back
Disease control OngoingThis study tests whether adding the immunotherapy drug durvalumab to precise radiation therapy (SBRT) can better control early-stage non-small cell lung cancer compared to radiation alone. About 13 adults with stage I to IIIA lung cancer received the combination. The main goal is…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE II
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:54 UTC
-
New keytruda copycat tested in lung cancer patients
Disease control OngoingThis study compares a new drug, SB27, to the approved cancer medicine Keytruda in people with early-stage non-small cell lung cancer who have already had surgery and chemotherapy. The goal is to see if SB27 stays in the body the same way as Keytruda. About 163 adults will receive…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE II
Phase: PHASE1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC